OngoingEUCTR 2019-001834-33
Sodium Oxybate for Addiction
This study is ongoing in Italy. It is testing sodium Oxybate for Addiction.
In ItalyAddictionOther
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00150553
SPD417 for Bipolarity
This study is completed. It is testing SPD417 for Bipolarity.
Location not clearly listedBipolarityDrugA study involving a medication or substance.Over 18 Years
CompletedNCT00150579
SPD465 for ADHD
This study is completed. It is testing SPD465 for ADHD.
Location not clearly listedADHDDrugFrom 18 Years to 55 Years
CompletedNCT00152022
SPD465 for ADHD
This study is completed. It is testing SPD465 for ADHD.
Location not clearly listedADHDDrugFrom 18 Years to 55 Years
CompletedNCT00734578
SPD503 for ADHD
This study is completed in the United States. It is testing SPD503 for ADHD.
Multiple locations, including DothanADHDDrugFrom 6 Years to 17 Years
CompletedNCT02633527
SPN-812 (Viloxazine Extended-release Capsule) for ADHD
This study is completed in the United States. It is testing SPN-812 (Viloxazine Extended-release Capsule) for ADHD.
In MaitlandADHDDrugFrom 6 Years to 12 Years
CompletedEUCTR 2006-005025-31
St. John´s Wort/Valerian Extract (Sedariston Concentrate) for ADHD
This study is completed in Germany. It is testing st.
In GermanyADHDOther
CompletedNCT00782080
St. John´s Wort/Valerian Extract for ADHD
This study is completed in Germany. It is testing st.
Multiple locations, including AlzeyADHDDrugFrom 6 Years to 17 Years
CompletedNCT06782763
Task-activated rTMS for Bipolarity
This study is completed in China. It is testing Task-activated rTMS for Bipolarity.
In HangzhouBipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 14 Years to 45 Years
Active Not RecruitingNCT07184697
Efficacy and Safety of Task-specific, Biomarker-driven, HD-ctACS inTRD.
This study is active but not recruiting in China. It focuses on Depression.
In ShanghaiDepressionDeviceFrom 18 Years to 65 Years
CompletedEUCTR 2012-005612-26
Tianeptine oral administration (25 to 50 mg/day) for depression
This study is completed in Slovakia, in Finland, in Estonia, .... It is testing tianeptine oral administration (25 to 50 mg/day) for depression.
In SlovakiaDepressionOther
UnknownNCT06270433
Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression
This study has an unknown status in China. It is testing Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia for depression.
In NanjingDepressionDrugFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.